ProjectA Randomized, Double-blind, Multicenter, Active-Controlled Study of Intranasal Esketamine Plus an Oral…
Basic data
Title:
A Randomized, Double-blind, Multicenter, Active-Controlled Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Treatment-resistant Depression
Duration:
19/10/2015 to 31/10/2016
Abstract / short description:
This study will investigate whether repeated use of intranasal esketamine plus an oral antidepressant (active comparator) plus intransal placebo in delaying relapse of depressive sympptoms in subjects with treatment-resistant depression who are stable in remission after an induction and optimization course of intransal esketamine plus an oral antidepressant.
Keywords:
Esketamin (esketamine)
depression
Depression
treatment resistance
Therapieresistenz
Involved staff
Managers
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of General psychiatry and psychotherapy with outpatient clinic
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Neuss, Nordrhein-Westfalen, Germany